1. Home
  2. VALN vs IVVD Comparison

VALN vs IVVD Comparison

Compare VALN & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • IVVD
  • Stock Information
  • Founded
  • VALN 2012
  • IVVD 2020
  • Country
  • VALN France
  • IVVD United States
  • Employees
  • VALN N/A
  • IVVD N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • IVVD Biotechnology: Pharmaceutical Preparations
  • Sector
  • VALN Health Care
  • IVVD Health Care
  • Exchange
  • VALN Nasdaq
  • IVVD Nasdaq
  • Market Cap
  • VALN 820.0M
  • IVVD 692.7M
  • IPO Year
  • VALN 2021
  • IVVD 2021
  • Fundamental
  • Price
  • VALN $9.43
  • IVVD $2.31
  • Analyst Decision
  • VALN Strong Buy
  • IVVD Strong Buy
  • Analyst Count
  • VALN 4
  • IVVD 4
  • Target Price
  • VALN $15.75
  • IVVD $8.33
  • AVG Volume (30 Days)
  • VALN 21.9K
  • IVVD 11.8M
  • Earning Date
  • VALN 11-20-2025
  • IVVD 11-06-2025
  • Dividend Yield
  • VALN N/A
  • IVVD N/A
  • EPS Growth
  • VALN N/A
  • IVVD N/A
  • EPS
  • VALN N/A
  • IVVD N/A
  • Revenue
  • VALN $211,089,992.00
  • IVVD $50,039,000.00
  • Revenue This Year
  • VALN $6.86
  • IVVD $102.11
  • Revenue Next Year
  • VALN $11.85
  • IVVD $151.51
  • P/E Ratio
  • VALN N/A
  • IVVD N/A
  • Revenue Growth
  • VALN 13.48
  • IVVD 332.71
  • 52 Week Low
  • VALN $3.62
  • IVVD $0.35
  • 52 Week High
  • VALN $12.25
  • IVVD $3.07
  • Technical
  • Relative Strength Index (RSI)
  • VALN 56.66
  • IVVD 57.56
  • Support Level
  • VALN $8.53
  • IVVD $2.23
  • Resistance Level
  • VALN $8.92
  • IVVD $2.70
  • Average True Range (ATR)
  • VALN 0.33
  • IVVD 0.24
  • MACD
  • VALN 0.07
  • IVVD 0.02
  • Stochastic Oscillator
  • VALN 89.57
  • IVVD 55.79

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: